According to Hanmi Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.73733. At the end of 2023 the company had a P/S ratio of 2.17.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.17 | -0.11% |
2022 | 2.17 | -41.97% |
2021 | 3.74 | -40.42% |
2020 | 6.28 | 105.75% |
2019 | 3.05 | -55.33% |
2018 | 6.84 | -38.19% |
2017 | 11.1 | 121.84% |
2016 | 4.99 | -44.57% |
2015 | 9.00 | 510.98% |
2014 | 1.47 | -50.36% |
2013 | 2.97 | -84.59% |
2012 | 19.2 | 38.43% |
2011 | 13.9 | 6856% |
2010 | 0.1999 | -88.99% |
2009 | 1.82 | 17.9% |
2008 | 1.54 |